Return to Home Incidence > Table

Incidence Rates Table

Data Options

Incidence Rate Report by State

Liver & Bile Duct (Late Stage^), 2014-2018

All Races (includes Hispanic), Both Sexes, All Ages

Sorted by Name
State
 sort alphabetically by name descending
Met Healthy People Objective of ***?
Age-Adjusted Incidence Rate
cases per 100,000
(95% Confidence Interval)
 sort by rate descending
CI*Rank⋔
(95% Confidence Interval)
 sort by CI rank descending
Average Annual Count
 sort by count descending
Percent of Cases with Late Stage
 sort by percent late descending
US (SEER+NPCR) 1 *** 3.5 (3.5, 3.6) N/A 14,221 41.2
Alabama 6 *** 2.6 (2.4, 2.7) 44 (40, 48) 165 32.5
Alaska 6 *** 3.7 (3.1, 4.4) 13 (1, 42) 29 41.6
Arizona 6 *** 2.9 (2.7, 3.0) 41 (33, 45) 251 35.5
Arkansas 6 *** 3.5 (3.3, 3.8) 21 (7, 34) 134 42.6
California 3 *** 3.9 (3.8, 4.0) 10 (5, 14) 1,733 39.4
Colorado 6 *** 2.9 (2.7, 3.1) 40 (32, 45) 184 38.0
Connecticut 3 *** 3.6 (3.4, 3.9) 15 (7, 31) 173 45.6
Delaware 6 *** 3.8 (3.3, 4.3) 11 (2, 35) 49 45.0
District of Columbia 6 *** 4.2 (3.5, 4.9) 4 (1, 32) 29 32.9
Florida 6 *** 3.3 (3.2, 3.4) 31 (23, 34) 985 41.0
Georgia 3 *** 4.1 (4.0, 4.3) 5 (3, 10) 489 50.1
Hawaii 3 *** 4.2 (3.8, 4.7) 3 (1, 17) 79 39.6
Idaho 3 *** 3.4 (3.0, 3.7) 30 (8, 42) 68 43.6
Illinois 6 *** 3.4 (3.2, 3.5) 28 (17, 33) 528 42.5
Indiana 6 *** 3.4 (3.2, 3.5) 29 (15, 35) 277 45.4
Iowa 3 *** 3.4 (3.1, 3.7) 27 (11, 37) 134 48.3
Kansas 6 *** 3.0 (2.8, 3.3) 37 (24, 44) 107 42.1
Kentucky 3 *** 3.9 (3.6, 4.1) 9 (3, 21) 219 45.5
Louisiana 3 *** 4.7 (4.4, 4.9) 1 (1, 4) 272 44.9
Maine 6 *** 2.5 (2.2, 2.8) 45 (37, 50) 52 42.9
Maryland 6 *** 3.6 (3.4, 3.8) 16 (8, 30) 269 41.0
Michigan 5 *** 2.9 (2.8, 3.1) 38 (32, 43) 392 41.1
Minnesota 6 *** 3.4 (3.2, 3.6) 26 (13, 35) 229 45.1
Mississippi 6 *** 4.1 (3.8, 4.4) 6 (2, 18) 150 44.9
Missouri 6 *** 3.6 (3.4, 3.8) 19 (10, 31) 283 45.0
Montana 6 *** 2.7 (2.3, 3.1) 43 (27, 49) 40 40.9
Nebraska 6 *** 2.2 (2.0, 2.5) 49 (43, 50) 52 39.8
Nevada 6 *** 2.1 (1.8, 2.3) 50 (45, 50) 59 30.1
New Hampshire 6 *** 2.3 (2.0, 2.7) 47 (40, 50) 43 36.9
New Jersey 3 *** 3.4 (3.3, 3.6) 25 (14, 33) 386 42.4
New Mexico 3 *** 3.2 (2.9, 3.5) 32 (14, 43) 85 31.8
New York 3 *** 4.0 (3.8, 4.1) 7 (4, 13) 977 43.7
North Carolina 6 *** 3.9 (3.8, 4.1) 8 (3, 14) 504 45.9
North Dakota 6 *** 2.8 (2.3, 3.4) 42 (16, 50) 24 51.3
Ohio 6 *** 3.0 (2.9, 3.2) 36 (31, 42) 460 40.8
Oklahoma 6 *** 3.1 (2.9, 3.3) 33 (22, 42) 151 36.4
Oregon 6 *** 3.6 (3.4, 3.8) 17 (7, 32) 197 38.4
Pennsylvania 6 *** 3.8 (3.6, 3.9) 12 (7, 20) 655 43.2
Puerto Rico 6 *** 1.6 (1.5, 1.8) N/A 77 19.6
Rhode Island 6 *** 3.5 (3.0, 4.0) 23 (4, 42) 48 40.6
South Carolina 6 *** 3.5 (3.3, 3.7) 22 (10, 33) 232 42.6
South Dakota 6 *** 3.1 (2.6, 3.6) 34 (10, 47) 33 45.4
Tennessee 6 *** 3.5 (3.3, 3.6) 24 (12, 33) 295 40.1
Texas 6 *** 4.5 (4.3, 4.6) 2 (1, 5) 1,311 37.2
Utah 3 *** 2.9 (2.6, 3.2) 39 (27, 46) 79 44.6
Vermont 6 *** 2.4 (1.9, 2.9) 46 (34, 50) 21 43.7
Virginia 6 *** 3.1 (2.9, 3.2) 35 (29, 42) 317 40.7
Washington 5 *** 3.7 (3.5, 3.8) 14 (8, 27) 331 40.5
West Virginia 6 *** 3.5 (3.2, 3.9) 20 (5, 36) 93 46.0
Wisconsin 6 *** 3.6 (3.4, 3.8) 18 (9, 31) 267 48.2
Wyoming 6 *** 2.2 (1.8, 2.8) 48 (36, 50) 17 37.2
Massachusetts 3 ***
data not available
N/A
data not available
data not available
Notes:
Created by statecancerprofiles.cancer.gov on 05/27/2022 1:21 am.

State Cancer Registries may provide more current or more local data.
Trend
Rising when 95% confidence interval of average annual percent change is above 0.
Stable when 95% confidence interval of average annual percent change includes 0.
Falling when 95% confidence interval of average annual percent change is below 0.

⋔ Results presented with the CI*Rank statistics help show the usefulness of ranks. For example, ranks for relatively rare diseases or less populated areas may be essentially meaningless because of their large variability, but ranks for more common diseases in densely populated regions can be very useful. More information about methodology can be found on the CI*Rank website.

† Incidence rates (cases per 100,000 population per year) are age-adjusted to the 2000 US standard population (19 age groups: <1, 1-4, 5-9, ... , 80-84, 85+). Rates are for invasive cancer only (except for bladder cancer which is invasive and in situ) or unless otherwise specified. Rates calculated using SEER*Stat. Population counts for denominators are based on Census populations as modified by NCI. The 1969-2018 US Population Data File is used for SEER and NPCR incidence rates.

Rates are computed using cancers classified as malignant based on ICD-O-3. For more information see malignant.html.

^ Late Stage is defined as cases determined to be regional or distant. Due to changes in stage coding, Combined Summary Stage (2004+) is used for data from Surveillance, Epidemiology, and End Results (SEER) databases and Merged Summary Stage is used for data from National Program of Cancer Registries databases. Due to the increased complexity with staging, other staging variables maybe used if necessary.
*** No Healthy People 2020 Objective for this cancer.
Healthy People 2020 Objectives provided by the Centers for Disease Control and Prevention.

Data not available for this combination of data selections.

1 Source: National Program of Cancer Registries and Surveillance, Epidemiology, and End Results SEER*Stat Database (2001-2018) - United States Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute. Based on the 2020 submission.
3 Source: SEER November 2020 submission. State Cancer Registry also receives funding from CDC's National Program of Cancer Registries.
5 Source: National Program of Cancer Registries and Surveillance, Epidemiology, and End Results SEER*Stat Database (2001-2018) - United States Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute. Based on the 2020 submission.
6 Source: National Program of Cancer Registries SEER*Stat Database (2001-2018) - United States Department of Health and Human Services, Centers for Disease Control and Prevention (based on the 2020 submission).

Interpret Rankings provides insight into interpreting cancer incidence statistics. When the population size for a denominator is small, the rates may be unstable. A rate is unstable when a small change in the numerator (e.g., only one or two additional cases) has a dramatic effect on the calculated rate.

Data not available for this combination of geography, cancer site, age, and race/ethnicity.

Data for United States does not include Puerto Rico.
CI*Rank data for Puerto Rico is not available.

Return to Top